NCT01689766
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Baylor College of Medicine Houston, Texas, United States
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT03679767
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
- Locations
-
- California Cancer Associates for Research and Excellence, Inc. Fresno, California, United States
- California Cancer Associates for Research and Excellence Fresno, California, United States
- California Cancer Associates for Research and Excellence, Inc. San Marcos, California, United States
- St Joseph Heritage Healthcare Santa Rosa, California, United States
NCT02627963
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- University Of UA Cancer Center(UACC)/DH-SJHMC Phoenix, Arizona, United States
- Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
- Arizona Oncology - Phoenix - Deer Valley Women's Center Loca Phoenix, Arizona, United States
- Arizona Oncology - Scottsdale Scottsdale, Arizona, United States
NCT00068393
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
- Rush-Copley Cancer Care Center Aurora, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
Completed
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
NCT03829436
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
- Locations
-
- University of California - San Francisco San Francisco, California, United States
- Miami Cancer Institute Miami, Florida, United States
- Johns Hopkins University Baltimore, Maryland, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
NCT02579811
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus, Ohio, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT01689662
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Baylor College of Medicine Houston, Texas, United States
NCT00003308
- Conditions
- Adenocarcinoma, Adnexal Diseases, Brain Diseases, +54 more
- Locations
-
- Iowa Methodist Medical Center Des Moines, Iowa, United States
- Mercy Medical Center Des Moines, Iowa, United States
- Iowa Lutheran Hospital Des Moines, Iowa, United States
- CCOP - Kalamazoo Kalamazoo, Michigan, United States
NCT00039429
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
Completed
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
NCT04440943
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
- Locations
-
- Northside Hospital Atlanta, Georgia, United States
- University of Chicago Chicago, Illinois, United States
- Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
- Duke Cancer Center Durham, North Carolina, United States